NCT01468090 Disease Course in an IBD Cohort in the Era of Biological Treatment Status COMPLETED Phase N/A
NCT01466374 Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease Status COMPLETED Phase PHASE2
NCT01464333 Special Investigation (Long-term Investigation) in Patients With Crohn's Disease Status COMPLETED Phase N/A
NCT01453946 Safety and Maintenance Study of Entocort for Children With Crohn's Disease Status COMPLETED Phase PHASE3
NCT01442025 Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease Status COMPLETED Phase PHASE4
NCT01438151 Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease Status TERMINATED Phase NA
NCT01434693 Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease Status COMPLETED Phase PHASE1
NCT01393899 The Safety And Efficacy Of Maintenance Therapy With CP-690,550 Status COMPLETED Phase PHASE2
NCT01393626 A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT01392365 Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease Status COMPLETED Phase N/A
NCT01388933 A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease Status TERMINATED Phase PHASE2
NCT01387594 Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs Status COMPLETED Phase PHASE1
NCT01372969 Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease. Status COMPLETED Phase PHASE1/PHASE2
NCT01369355 A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) Status COMPLETED Phase PHASE3
NCT01369342 A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) Status COMPLETED Phase PHASE3